In MS cases, this interleukin has been shown to be released from microglia/macrophages via P2X7R-dependent induction of cyclooxygenase-2 and downstream pathogenic mediators (Yiangou et al. 2006). Here, PTGS2 is linked to myeloid sarcoma.